OTEZLA STARTER (apremilast)
ANTIPSORIATICS·PSORIATIC ARTHRITIS·+2
AMGEN
Indication
Psoriatic arthritis
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50. Read more about Psoriatic arthritis
547 drugs 201 manufacturers
Drugs that treat it
Common Psoriatic arthritis therapies.
CELESTONE SOLUSPAN (betamethasone acetate/betamethasone sodium phosphate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+53
ORGANON LLC
DEPO-MEDROL (methylprednisolone acetate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+43
Laboratories Div
MEDROL (PAK) (methylprednisolone)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+55
Pfizer Laboratories
CORTROPHIN GEL (corticotropin)
CORTICOTROPINS·CHORIORETINITIS·+17
ANI PHARMACEUTI
HUMIRA (adalimumab)
ANTIPSORIATICS·CROHN'S DISEASE·+8
ABBOTT
HUMIRA PEN CROHNS-UC-HS START (adalimumab)
ANTIPSORIATICS·CROHN'S DISEASE·+8
ABBOTT
MILLIPRED (prednisolone)
TRICHINOSIS·+59
AVALO THERAPEUT
HUMIRA PEN PSOR-UVEITS-ADOL HS (adalimumab)
ANTIPSORIATICS·CROHN'S DISEASE·+8
ABBOTT
Filter & compare in the drug finder →Opens the drug finder with Psoriatic arthritis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPsoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50.
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes.
Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement.
Driven by dysregulated immune pathways including tumor necrosis factor and the interleukin-23/interleukin-17 axis, unchecked inflammation can lead to progressive articular cartilage destruction and pathologic bone remodeling.
- medlineplus.gov
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50 It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalange...
- nih.gov
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50 It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes Driven by dysregulated immune pathways including tumor necrosis factor and the interleukin-23/interleukin-17 axis, u...
- nih.gov
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50
- nih.gov
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes
- nih.gov
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement
- nih.gov
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes
- nih.gov
Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement
- nih.gov
Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement
Personalize your experience
Follow Psoriatic arthritis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.